Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's National Health System, Washington, DC.
Division of Pediatric Critical Care Medicine, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
Pediatr Crit Care Med. 2020 Aug;21(8):708-719. doi: 10.1097/PCC.0000000000002310.
To characterize contemporary use of inhaled nitric oxide in pediatric acute respiratory failure and to assess relationships between clinical variables and outcomes. We sought to study the relationship of inhaled nitric oxide response to patient characteristics including right ventricular dysfunction and clinician responsiveness to improved oxygenation. We hypothesize that prompt clinician responsiveness to minimize hyperoxia would be associated with improved outcomes.
An observational cohort study.
Eight sites of the Collaborative Pediatric Critical Care Research Network.
One hundred fifty-one patients who received inhaled nitric oxide for a primary respiratory indication.
Clinical data were abstracted from the medical record beginning at inhaled nitric oxide initiation and continuing until the earliest of 28 days, ICU discharge, or death. Ventilator-free days, oxygenation index, and Functional Status Scale were calculated. Echocardiographic reports were abstracted assessing for pulmonary hypertension, right ventricular dysfunction, and other cardiovascular parameters. Clinician responsiveness to improved oxygenation was determined. One hundred thirty patients (86%) who received inhaled nitric oxide had improved oxygenation by 24 hours. PICU mortality was 29.8%, while a new morbidity was identified in 19.8% of survivors. Among patients who had echocardiograms, 27.9% had evidence of pulmonary hypertension, 23.1% had right ventricular systolic dysfunction, and 22.1% had an atrial communication. Moderate or severe right ventricular dysfunction was associated with higher mortality. Clinicians responded to an improvement in oxygenation by decreasing FIO2 to less than 0.6 within 24 hours in 71% of patients. Timely clinician responsiveness to improved oxygenation with inhaled nitric oxide was associated with more ventilator-free days but not less cardiac arrests, mortality, or additional morbidity.
Clinician responsiveness to improved oxygenation was associated with less ventilator days. Algorithms to standardize ventilator management may improve signal to noise ratios in future trials enabling better assessment of the effect of inhaled nitric oxide on patient outcomes. Additionally, confining studies to more selective patient populations such as those with right ventricular dysfunction may be required.
描述儿科急性呼吸衰竭患者中吸入一氧化氮的当代应用,并评估临床变量与结局之间的关系。我们试图研究吸入一氧化氮的反应与患者特征(包括右心室功能障碍和临床医生对改善氧合的反应)之间的关系。我们假设,临床医生对最小化高氧血症的及时反应与改善结局相关。
观察性队列研究。
合作儿科危重病研究网络的 8 个地点。
151 名因原发性呼吸原因接受吸入一氧化氮治疗的患者。
从开始使用吸入一氧化氮的病历中提取临床数据,并继续记录至 28 天、重症监护病房出院或死亡的最早时间。计算无呼吸机天数、氧合指数和功能状态量表。提取超声心动图报告评估肺动脉高压、右心室功能障碍和其他心血管参数。确定临床医生对改善氧合的反应。130 名(86%)接受吸入一氧化氮治疗的患者在 24 小时内氧合得到改善。儿科重症监护病房死亡率为 29.8%,而幸存者中有 19.8%出现新的发病率。在接受超声心动图检查的患者中,27.9%有肺动脉高压证据,23.1%有右心室收缩功能障碍,22.1%有房间隔沟通。中度或重度右心室功能障碍与更高的死亡率相关。在 71%的患者中,临床医生在 24 小时内通过将 FIO2 降低至 0.6 以下来响应氧合的改善。及时响应吸入一氧化氮改善氧合与更多的无呼吸机天数相关,但与心脏骤停、死亡率或其他发病率的减少无关。
临床医生对改善氧合的反应与减少呼吸机天数相关。标准化呼吸机管理的算法可能会提高未来试验中的信号噪声比,从而更好地评估吸入一氧化氮对患者结局的影响。此外,可能需要将研究限制在更具选择性的患者人群,例如那些有右心室功能障碍的患者。